New Drugs 2021, Part 2.

Hussar, Daniel A

Hussar, Daniel A.

Hussar DA; DEAN EMERITUS AND REMINGTON PROFESSOR EMERITUS â¢ PHILADELPHIA COLLEGE OF PHARMACY UNIVERSITY OF THE SCIENCES â¢ PHILADELPHIA, PA.

Nursing ; 51(10): 18-29, 2021 Oct 01.

Article in English | MEDLINE | ID: covidwho-1440656

ABSTRACT

ABSTRACT

ABSTRACT The second of a two-part series, this article describes eight recently approved drugs, including the first drug approved for the treatment of SARS-CoV-2, a first-in-class HIV attachment inhibitor, and a new intravenous injection indicated for the treatment of acute pain in adults for whom other treatments are ineffective.

Subject(s)

Drug Approval; Adenosine Monophosphate/analogs & derivatives; Adenosine Monophosphate/therapeutic use; Alanine/analogs & derivatives; Alanine/therapeutic use; Amisulpride/therapeutic use; Carbamates/therapeutic use; Cephalosporins/therapeutic use; Chlorophenols/therapeutic use; Drug Combinations; Fumarates/therapeutic use; Humans; Indans/therapeutic use; Organophosphates/therapeutic use; Oxadiazoles/therapeutic use; Piperazines/therapeutic use; Spiro Compounds/therapeutic use; Tetrazoles/therapeutic use; Thiophenes/therapeutic use; Tromethamine/therapeutic use; United States; United States Food and Drug Administration; COVID-19 Drug Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Drug Approval Limits: Humans Country/Region as subject: North America Language: English Journal: Nursing Year: 2021 Document Type: Article Affiliation country: 01.NURSE.0000791756.56705.dd

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google